Social Sentiment for NBY
Bullish vs. Bearish opinions
Weighted Sentiment 0.91
NovaBay Pharmaceuticals, Inc Forecast and Stock Analysis
Technical NBY stock analysis for Thursday May 23, 2019.
|Shorts||1.88% ( 2019-04-15 )|
|Price to book||USD 4.83|
|Next Earnings Date||2019-08-07|
NovaBay Pharmaceuticals, Inc gained 3.76% in the last trading day ( Thursday, 23rd May 2019 ), rising from $0.29 to $0.30 During day the stock fluctuated 48.15% from a day low at $0.27 to a day high of $0.40. The price has fallen in 8 of the last 10 days and is down by -47.68% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 1.20 million more shares were traded than the day before. In total, 1.67 million shares bought and sold for approximately $498 630.00.
- 30 day high of the NBY stock price was $1.22 and low was $0.23.
- 90 day high was $1.75 and low was $0.23.
- 52 week high for the NovaBay Pharmaceuticals, Inc - $3.75 and low - $0.23.
NovaBay Pharmaceuticals, Inc lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -61.80% during the next 3 months and, with 90% probability hold a price between $0.06 and $0.26 at the end of this period.
A buy signal was issued from a pivot bottom point on Wednesday May 22, 2019, which indicates further gains until a new top pivot has been found. NovaBay Pharmaceuticals, Inc has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. NovaBay Pharmaceuticals, Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $0.37 and $0.82. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 30 and the stock is currently not being overbought or oversold
Support & Resistance
NovaBay Pharmaceuticals, Inc finds support from accumulated volume at $0.29.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 48.15%. For the last week, the stock has had a daily average volatility of 26.34%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
26.34 %Average volatility
Very Low Low Medium High Very High
NovaBay Pharmaceuticals, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|NBY $0.30 ($0.01 3.76%)|
NBY is up $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for NBY based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the NBY analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us